Radix Actinidia chinensis Suppresses Renal Cell Carcinoma Progression: Network Pharmacology Prediction and In Vivo Experimental Validation

Figure 1

The component-target-disease network of RAC for RCC. Yellow circles represent the compound; red cycles represent the targets. Note: RAC: Radix Actinidia chinensis; RCC: renal cell carcinoma.